Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

FDA weighs whether Lasik patients should be given extra warning about possible risks

Por: ABC News Life December 08, 2022

thumbnail

The is weighing whether or not surgeons should provide additional warnings about the risks of , a popular corrective eye-sight surgery.In a draft guidance from July, the agency suggested that patients should be explicitly informed about the risks of dry eye, problems driving at night, visual disturbances – or other rare but more serious side effects related to the surgery.STOCK PHOTO/Getty ImagesThe FDA is still finalizing the guidance. If... + full article



Similar News

Panel warns FDA’s beleaguered tobacco unit lacks direction

ABC News USA Health December 20, 2022

thumbnailWASHINGTON -- The lack of clear direction and priorities at the U.S. Food and Drug Administration's tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más

Panel warns FDA’s beleaguered tobacco unit lacks direction | Associated Press

Panel warns FDA’s beleaguered tobacco unit lacks direction | WPLG Local 10


Panel warns FDA’s beleaguered tobacco unit lacks direction

WPLG Local 10 USA Politics December 20, 2022

thumbnailWASHINGTON – The lack of clear direction and priorities at the U.S. Food and Drug Administration's tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más

Panel warns FDA’s beleaguered tobacco unit lacks direction | ABC News

Panel warns FDA’s beleaguered tobacco unit lacks direction | Associated Press


Panel warns FDA’s beleaguered tobacco unit lacks direction

Associated Press USA Politics December 19, 2022

thumbnailWASHINGTON (AP) — The lack of clear direction and priorities at the U.S. Food and Drug Administration’s tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más

Panel warns FDA’s beleaguered tobacco unit lacks direction | ABC News

Panel warns FDA’s beleaguered tobacco unit lacks direction | WPLG Local 10


FDA warns that LASIK surgery patients need to be better informed of risks before procedure

New York Post USA Life December 13, 2022

thumbnailThe — Laser-Assisted In Situ Keratomileusis — is under the lens of the Food and Drug Administration (FDA), which is causing controversy among eye experts.  The FDA released a 25-page draft guidance after receiving input from patients who felt they were not fully informed... + más

FDA weighs whether Lasik patients should be given extra warning about possible risks | ABC News

Lasik patients should be warned of complications, FDA draft says | The Boston Globe


Lasik patients should be warned of complications, FDA draft says

The Boston Globe USA Nation December 08, 2022

thumbnailPatients considering Lasik surgery should be warned that they may be left with double vision, dry eyes, difficulty driving at night, and, in rare cases, persistent eye pain, according to draft guidance by the Food and Drug Administration. After surgery, patients might still need... + más

FDA weighs whether Lasik patients should be given extra warning about possible risks | ABC News

Lasik Patients Should Be Warned of Complications, F.D.A. Draft Says | The New York Times


Lasik Patients Should Be Warned of Complications, F.D.A. Draft Says

The New York Times USA Health December 07, 2022

thumbnailPatients considering Lasik surgery should be warned that they may be left with double vision, dry eyes, difficulty driving at night and, in rare cases, persistent eye pain, according to draft guidance by the Food and Drug Administration. After surgery, patients may still need... + más

FDA warns that LASIK surgery patients need to be better informed of risks before procedure | New York Post

Lasik patients should be warned of complications, FDA draft says | The Boston Globe


ALS drug wins FDA approval despite questionable data

ABC News USA Health September 30, 2022

thumbnailWASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | WPLG Local 10



About iurex | Privacy Policy | Disclaimer |